dextroamphetamine has been researched along with g(m1) ganglioside in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dunbar, GL; Lescaudron, LL; Stein, DG | 1 |
| Bellot, RG; Frussa-Filho, R; Palermo-Neto, J; Vital, MA | 1 |
2 other study(ies) available for dextroamphetamine and g(m1) ganglioside
| Article | Year |
|---|---|
Comparison of GM1 ganglioside, AGF2, and D-amphetamine as treatments for spatial reversal and place learning deficits following lesions of the neostriatum.
Topics: Adenosine Monophosphate; Animals; Brain Mapping; Cell Count; Dextroamphetamine; Discrimination Learning; Electroshock; G(M1) Ganglioside; Injections, Intraperitoneal; Male; Neostriatum; Neuroglia; Neurons; Orientation; Rats; Rats, Sprague-Dawley; Reversal Learning; Sensory Thresholds | 1993 |
Repeated monosialoganglioside administration attenuates behavioral sensitization to amphetamine.
Topics: Animals; Central Nervous System Stimulants; Dextroamphetamine; G(M1) Ganglioside; Male; Mice; Motor Activity; Neuronal Plasticity | 1997 |